ClinicalTrials.gov
public full text
Public Domain
Collagenase in the Treatment of Dupuytrens Disease
The purpose of the study is to determine if collagenase will reduce the degree of contracture in the primary joint in subjects with Dupuytren's disease. This study was designed to be part of the larger clinical program, for adult patients with Dupuytren's contracture with a palpable cord, where the data from 2 pivotal Placebo-Controlled studies (AUX-CC-857 and AUX-CC-859) and 7 non-pivotal studies were evaluated.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Collagenase Option for Reduction of Dupuytren's Contracture in Japan#905144
- Clinical Investigation Plan - Post-market Clinical Follow-up Study Collagen Dura Membrane - Suturable#1279517
- Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease#860240
- Fasciectomy vs Collagenase Injection in Recurrent Dupuytren Disease#802332
- Treatment Of Dupuytren's Contracture With Collagenase Clostridium Histolyticum Injection (Xiapex)#804151
Record · ID 1292581
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive